Drug intelligence / Profile preview

nanocrystal megestrol acetate

Development stage
Unknown
Lead developer
Boryung
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Nanocrystal megestrol acetate is an advanced oral formulation of **megestrol acetate** engineered using nanocrystal technology to enhance its bioavailability, especially under fasting conditions. Traditional micronized megestrol acetate oral suspensions, such as Megace OS, have limited absorption when taken without food. The nanocrystal formulation overcomes this by allowing for rapid and efficient absorption, leading to significantly higher systemic drug exposure even in the fasting state. Megestrol acetate is a synthetic progestin used primarily to stimulate appetite and promote weight gain in patients with cancer-associated anorexia, cachexia, or wasting syndromes. It also possesses antineoplastic effects and has been used in therapy for certain cancers such as breast and endometrial cancer. The predominant mechanism of action is as an agonist at the progesterone receptor. The nanocrystal formulation does not alter the pharmacodynamics of megestrol acetate but significantly optimizes its pharmacokinetic profile[1][2][4][6].

Other names
nanoparticulate megestrol acetatenano-crystalline megestrol acetatenanocrystal formulation of megestrol acetate
02

Targets

GR (Glucocorticoid receptor)PR (Progesterone receptor)

Beyond the preview

Go deeper on nanocrystal megestrol acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nanocrystal megestrol acetate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call